0.3101
-0.0098 (-3.06%)
-0.0098 (-3.06%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Onconova Therapeutics Inc | ONTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.003 | -0.93% | 0.3199 | 0.30 | 0.3199 | 0.3188 | 0.3229 | 00:00:06 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 0.30 | 0.34 | 0.04 | 11.76% | 1 | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 6,167 | 4,571,428 | $ 0.31043 | $ 1,419,108 | 11,359,445 | 0.1027 - 5.25 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:15 | formt | 100 | $ 0.3101 | USD |
Onconova Therapeutics Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 44.38M | 138.73M | $ -20.57M | -1.50 | - | 137.22M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Onconova Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ONTX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.32 | 0.44 | 0.2922 | 0.3449448 | 10,393,364 | -0.0001 | -0.03% |
| 1 Month | 0.41 | 0.54 | 0.273 | 0.3938704 | 9,877,531 | -0.0901 | -21.98% |
| 3 Months | 0.42 | 0.749 | 0.273 | 0.460564 | 17,104,996 | -0.1001 | -23.83% |
| 6 Months | 1.06 | 1.21 | 0.1027 | 0.401744 | 14,591,332 | -0.7401 | -69.82% |
| 1 Year | 3.90 | 5.25 | 0.1027 | 0.4137733 | 7,316,562 | -3.58 | -91.8% |
| 3 Years | 45.90 | 58.20 | 0.1027 | 1.87 | 2,838,988 | -45.58 | -99.3% |
| 5 Years | 34.80 | 122.55 | 0.1027 | 2.88 | 1,769,814 | -34.48 | -99.08% |
Onconova Therapeutics Description
| Onconova Therapeutics Inc is a clinical-stage biopharmaceutical company operating in the US. It focuses on discovering and developing novel small molecule product candidates primarily to treat cancer. The company has created a library of targeted agents designed to work against cellular pathways important to cancer cells. Its product candidates are Single-agent IV rigosertib, Oral rigosertib + azacitidine, IV Briciclib, Recilisib, and ON 123300. The key product candidate Rigosertib is a small molecule which blocks cellular signaling by targeting RAS effector pathways. |
